SLC44A4 and neoplasm: Autophagy inhibition by chloroquine enhanced the antitumor response to dual immune checkpoint blockade (ICB) therapy, including anti-CTL4 and anti-PD-1, in a mouse model of PC, although the combined treatment was able to slow down tumor growth, but it did not lead to complete tumor eradication [50].